Crescita Therapeutics Inc. (TSX:CTX)
Canada flag Canada · Delayed Price · Currency is CAD
0.7500
0.00 (0.00%)
Apr 10, 2026, 12:06 PM EST

Crescita Therapeutics Income Statement

Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
21.1219.5817.5223.5316.77
Revenue Growth (YoY)
7.85%11.74%-25.52%40.29%7.22%
Cost of Revenue
10.0110.597.1610.346.76
Gross Profit
11.118.9910.3613.1810.01
Selling, General & Admin
10.8210.8110.1210.578.72
Depreciation & Amortization Expenses
0.740.751.511.471.38
Research & Development
0.570.650.70.610.63
Total Operating Expenses
12.1312.2112.3212.6510.73
Operating Income
-1.02-3.22-1.960.53-0.72
Interest Income
0.330.50.510.260.18
Interest Expense
-0.04-0.07-0.09-0.16-0.24
Other Non-Operating Income (Expense)
-1.130.1-0.02-0.130.25
Total Non-Operating Income (Expense)
-0.840.530.41-0.020.2
Pretax Income
-0.08-2.76-1.530.4-1.01
Provision for Income Taxes
0.01-0.010.46-0.460.1
Net Income
-0.09-2.75-1.990.86-1.11
Earnings From Discontinued Operations
1.47----
Net Income to Common
-0.09-2.75-1.990.86-1.11
Shares Outstanding (Basic)
1919202121
Shares Outstanding (Diluted)
1919202121
Shares Change (YoY)
-2.61%-4.44%-3.55%1.18%-1.02%
EPS (Basic)
--0.14-0.100.04-0.05
EPS (Diluted)
--0.14-0.100.04-0.05
Shares Outstanding
18.6119.0819.9620.3320.98
Free Cash Flow
0.741.541.94-1.25-1.94
Free Cash Flow Growth
-51.95%-20.74%---
Free Cash Flow Per Share
0.040.080.10-0.06-0.09
Gross Margin
52.60%45.91%59.15%56.03%59.72%
Operating Margin
-4.84%-16.42%-11.16%2.25%-4.29%
Profit Margin
-0.44%-14.04%-11.33%3.66%-6.59%
FCF Margin
3.50%7.87%11.09%-5.31%-11.59%
EBITDA
0.48-1.85-0.4520.66
EBITDA Margin
2.27%-9.44%-2.57%8.50%3.94%
EBIT
-1.02-3.22-1.960.53-0.72
EBIT Margin
-4.84%-16.42%-11.16%2.25%-4.29%
Effective Tax Rate
-10.84%0.51%-29.80%-113.37%-9.51%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.